Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

EEG spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients--a case control study.

Duffy FH, McAnulty GB, McCreary MC, Cuchural GJ, Komaroff AL.

BMC Neurol. 2011 Jul 1;11:82. doi: 10.1186/1471-2377-11-82.

PMID:
21722376
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996.

Snydman DR, Jacobus NV, McDermott LA, Supran S, Cuchural GJ Jr, Finegold S, Harrell L, Hecht DW, Iannini P, Jenkins S, Pierson C, Rihs J, Gorbach SL.

Antimicrob Agents Chemother. 1999 Oct;43(10):2417-22.

PMID:
10508018
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.

Snydman DR, McDermott L, Cuchural GJ Jr, Hecht DW, Iannini PB, Harrell LJ, Jenkins SG, O'Keefe JP, Pierson CL, Rihs JD, Yu VL, Finegold SM, Gorbach SL.

Clin Infect Dis. 1996 Dec;23 Suppl 1:S54-65.

PMID:
8953108
[PubMed - indexed for MEDLINE]
Free Article
4.

Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis.

Snydman DR, Cuchural GJ Jr, McDermott L, Gill M.

Antimicrob Agents Chemother. 1992 Mar;36(3):540-4.

PMID:
1622162
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.

Cuchural GJ Jr, Snydman DR, McDermott L, Iannini PB, Hill GB, Cleary TJ, O'Keefe JP, Pierson CL, Rihs JD, Finegold SM.

Clin Ther. 1992 Jan-Feb;14(1):122-36.

PMID:
1576621
[PubMed - indexed for MEDLINE]
6.

Newer beta-lactam agents and the Bacteroides fragilis group.

Cuchural GJ Jr.

Pharmacotherapy. 1991;11(2 ( Pt 2)):51S-55S. Review.

PMID:
2041832
[PubMed - indexed for MEDLINE]
7.

The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.

Cornick NA, Cuchural GJ Jr, Snydman DR, Jacobus NV, Iannini P, Hill G, Cleary T, O'Keefe JP, Pierson C, Finegold SM.

J Antimicrob Chemother. 1990 Jun;25(6):1011-9.

PMID:
2370237
[PubMed - indexed for MEDLINE]
8.

Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.

Cuchural GJ Jr, Tally FP, Jacobus NV, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, Pierson C.

Antimicrob Agents Chemother. 1990 Mar;34(3):479-80.

PMID:
2334161
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase.

Hurlbut S, Cuchural GJ, Tally FP.

Antimicrob Agents Chemother. 1990 Jan;34(1):117-20.

PMID:
2327745
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

In-vitro susceptibility of the Bacteroides fragilis group and the inoculum effect of newer beta-lactam antibiotics on this group of organisms.

Jacobus NV, Cuchural GJ Jr, Tally FP.

J Antimicrob Chemother. 1989 Nov;24(5):675-82.

PMID:
2599992
[PubMed - indexed for MEDLINE]
11.

Permeability to beta-lactams in Bacteroides fragilis.

Cuchural GJ, Hurlbut S, Malamy MH, Tally FP.

J Antimicrob Chemother. 1988 Dec;22(6):785-90.

PMID:
3266619
[PubMed - indexed for MEDLINE]
12.

Antibiotic resistance in anaerobic bacteria.

Tally FP, Cuchural GJ Jr.

J Antimicrob Chemother. 1988 Jul;22 Suppl A:63-71.

PMID:
3264832
[PubMed - indexed for MEDLINE]
13.

Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation.

Cuchural GJ Jr, Tally FP, Jacobus NV, Aldridge K, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, Pierson C, et al.

Antimicrob Agents Chemother. 1988 May;32(5):717-22.

PMID:
3395102
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Antimicrobial resistance in oral and colonic bacteroides.

Crook DW, Cuchural GJ Jr, Jacobus NV, Tally FP.

Scand J Infect Dis Suppl. 1988;57:55-64. Review.

PMID:
3074473
[PubMed - indexed for MEDLINE]
15.

Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates.

Bieluch VM, Cuchural GJ, Snydman DR, Gorbach SL, Tally FP.

Diagn Microbiol Infect Dis. 1987 Jun;7(2):119-26.

PMID:
3652652
[PubMed - indexed for MEDLINE]
16.

Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis.

Cuchural GJ Jr, Malamy MH, Tally FP.

Antimicrob Agents Chemother. 1986 Nov;30(5):645-8.

PMID:
3492173
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Bacteroides fragilis: current susceptibilities, mechanisms of drug resistance, and principles of antimicrobial therapy.

Cuchural GJ Jr, Tally FP.

Drug Intell Clin Pharm. 1986 Jul-Aug;20(7-8):567-73.

PMID:
3488895
[PubMed - indexed for MEDLINE]
18.

Transfer of beta-lactamase-associated cefoxitin resistance in Bacteroides fragilis.

Cuchural GJ Jr, Tally FP, Storey JR, Malamy MH.

Antimicrob Agents Chemother. 1986 May;29(5):918-20.

PMID:
3488018
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States.

Tally FP, Cuchural GJ Jr, Jacobus NV, Gorbach SL, Aldridge K, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, et al.

Antimicrob Agents Chemother. 1985 Nov;28(5):675-7.

PMID:
4091530
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.

Cuchural GJ Jr, Tally FP, Jacobus NV, Gorbach SL, Aldridge K, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, et al.

Antimicrob Agents Chemother. 1984 Aug;26(2):145-8.

PMID:
6486758
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk